Investigational and Comparative Study in the Management of Diabetic Nephropathy
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate and compare the safety and efficacy of
selective (PDE5) enzyme inhibitor; tadalafil and non selective (PDE) inhibitor;
pentoxifylline in diabetic nephropathy to improve glucose metabolism, lipid profile and
decrease albuminuria.